| Ident. | Authors (with country if any) | Title |
|---|
| 001B17 |
Kamel Mohammedi [Australie] ; Mark Woodward [États-Unis] ; Yoichiro Hirakawa [Australie] ; Sophia Zoungas [Australie] ; Bryan Williams [Royaume-Uni] ; Liu Lisheng [République populaire de Chine] ; Anthony Rodgers [Australie] ; Giuseppe Mancia [Italie] ; Bruce Neal [Australie] ; Stephen Harrap [Australie] ; Michel Marre [France] ; John Chalmers [Australie] | Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes. |
| 001B82 |
Muh Geot Wong [Australie] ; Vlado Perkovic [Australie] ; John Chalmers [Australie] ; Mark Woodward [États-Unis] ; Qiang Li [Australie] ; Mark E. Cooper [Australie] ; Pavel Hamet [Canada] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Michel Marre [France] ; David Matthews [Royaume-Uni] ; Bruce Neal [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Anthony Rodgers [Australie] ; Bryan Williams [Royaume-Uni] ; Sophia Zoungas [Australie] | Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON. |
| 002897 |
Merlin C. Thomas [Australie] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; Qiang Li [Australie] ; Raelene Pickering [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Vlado Perkovic [Australie] ; Mark E. Cooper [Australie] ; Sophia Zoungas [Australie] ; John Chalmers [Australie] ; Graham S. Hillis [Australie] | Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes. |
| 003A59 |
Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Stephen Harrap [Australie] ; Lisheng Liu [République populaire de Chine] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial. |
| 003B72 |
Lisa Manning [Royaume-Uni] ; Yoichiro Hirakawa [Australie] ; Hisatomi Arima [Australie] ; Xia Wang [Australie] ; John Chalmers [Australie] ; Jiguang Wang [République populaire de Chine] ; Richard Lindley [Australie] ; Emma Heeley [Australie] ; Candice Delcourt [Australie] ; Bruce Neal [Australie] ; Pablo Lavados [Chili] ; Stephen M. Davis [Australie] ; Christophe Tzourio [France] ; Yining Huang [République populaire de Chine] ; Christian Stapf [France] ; Mark Woodward [Australie] ; Peter M. Rothwell [Royaume-Uni] ; Thompson G. Robinson [Royaume-Uni] ; Craig S. Anderson [Australie] | Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. |
| 004D17 |
Craig S. Anderson [Australie] ; Emma Heeley [Australie] ; YINING HUANG [République populaire de Chine] ; JIGUANG WANG [République populaire de Chine] ; Christian Stapf [France] ; Candice Delcourt [Australie] ; Richard Lindley [Australie] ; Thompson Robinson [Royaume-Uni] ; Pablo Lavados [Chili] ; Bruce Neal [Australie] ; Jun Hata [Australie, Japon] ; Hisatomi Arima [Australie] ; Mark Parsons [Australie] ; YUECHUN LI ; JINCHAO WANG [République populaire de Chine] ; Stephane Heritier [Australie] ; QIANG LI [Australie] ; Mark Woodward [Australie, États-Unis] ; R. John Simes [Australie] ; Stephen M. Davis [Australie] ; John Chalmers [Australie] | Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage |
| 005D02 |
Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie, Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Anthony Rodgers [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial |
| 006013 |
Colin Baigent [Royaume-Uni] ; Martin J. Landray [Royaume-Uni] ; Christina Reith [Royaume-Uni] ; Jonathan Emberson [Royaume-Uni] ; David C. Wheeler [Royaume-Uni] ; Charles Tomson [Royaume-Uni] ; Christoph Wanner [Allemagne] ; Vera Krane [Allemagne] ; Alan Cass [Australie] ; Jonathan Craig [Australie] ; Bruce Neal [Australie] ; Lixin Jiang [République populaire de Chine] ; Lai Seong Hooi [Malaisie] ; Adeera Levin [Canada] ; Lawrence Agodoa [États-Unis] ; Mike Gaziano [États-Unis] ; Bertram Kasiske [États-Unis] ; Robert Walker [Nouvelle-Zélande] ; Ziad A. Massy [France] ; Bo Feldt-Rasmussen [Danemark] ; Udom Krairittichai [Thaïlande] ; Vuddidhej Ophascharoensuk [Thaïlande] ; Bengt Fellström [Suède] ; Hallvard Holdaas [Norvège] ; Vladimir Tesar [République tchèque] ; Andrzej Wiecek [Pologne] ; Diederick Grobbee [Pays-Bas] ; Dick De Zeeuw [Pays-Bas] ; Carola Grönhagen-Riska [Finlande] ; Tanaji Dasgupta [Royaume-Uni] ; David Lewis [Royaume-Uni] ; William Herrington [Royaume-Uni] ; Marion Mafham [Royaume-Uni] ; William Majoni [Australie] ; Karl Wallendszus [Royaume-Uni] ; Richard Grimm [États-Unis] ; Terje Pedersen [Norvège] ; Jonathan Tobert [États-Unis] ; Jane Armitage [Royaume-Uni] ; Alex Baxter [Royaume-Uni] ; Christopher Bray [Royaume-Uni] ; Yiping Chen [Royaume-Uni] ; Zhengming Chen [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Carol Knott [Royaume-Uni] ; Sarah Parish [Royaume-Uni] ; David Simpson [Royaume-Uni] ; Peter Sleight [Royaume-Uni] ; Alan Young [Royaume-Uni] ; Rory Collins [Royaume-Uni] | The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial |
| 006635 |
Sébastien Czernichow [Australie, France] ; Alberto Zanchetti [Italie] ; Fiona Turnbull [Australie] ; Federica Barzi [Australie] ; Toshiaru Ninomiya [Australie] ; André-Pascal Kengne [Australie] ; Hiddo J. Lambers Heerspink [Pays-Bas] ; Vlado Perkovic [Australie] ; Rachel Huxley [Australie] ; Hisatomi Arima [Australie] ; Anushka Patel [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] | The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials |
| 007548 |
Sophia Zoungas [Australie] ; Anushka Patel [Australie] ; John Chalmers [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; QIANG LI [Australie] ; M. Biostat [Australie] ; Laurent Billot [Australie] ; Mark Woodward [États-Unis] ; Toshiharu Ninomiya [Australie] ; Bruce Neal [Australie] ; Stephen Macmahon [Australie] ; Diederick E. Grobbee [Pays-Bas] ; Andre Pascal Kengne [Australie] ; Michel Marre [France] ; Simon Heller [Royaume-Uni] | Severe Hypoglycemia and Risks of Vascular Events and Death |
| 007801 |
Sébastien Czernichow [Australie, France] ; Toshiharu Ninomiya [Australie] ; Rachel Huxley [Australie] ; André-Pascal Kengne [Australie] ; G. David Batty [Australie, Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial |
| 007877 |
G. David Batty [Royaume-Uni, Australie] ; QIANG LI [Australie] ; Sébastien Czernichow [Australie, France] ; Bruce Neal [Australie] ; Sophia Zoungas [Australie] ; Rachel Huxley [Australie] ; Anushka Patel [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Mark Woodward [Australie, États-Unis] ; Pavel Hamet [Canada] ; Stephen B. Harrap [Australie] ; Neil Poulter [Royaume-Uni] ; John Chalmers [Australie] | Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) Trial |
| 007911 |
Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Craig Anderson [Australie] ; Mark Woodward [États-Unis] ; Marie-Germaine Bousser [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie] | Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial |
| 008235 |
Bastiaan E. De Galan [Australie, Pays-Bas] ; Vlado Perkovic [Australie] ; Toshiharu Ninomiya [Australie] ; Avinesh Pillai [Australie] ; Anushka Patel [Australie] ; Alan Cass [Australie] ; Bruce Neal [Australie] ; Neil Poulter [Royaume-Uni] ; Stephen Harrap [Australie] ; Carl-Erik Mogensen [Danemark] ; Mark Cooper [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Pavel Hamet [Canada] ; Giuseppe Mancia [Italie] ; Mark Woodward [Australie] ; Paul Glasziou [Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] | Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes |
| 008421 |
Sophia Zoungas [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Diederick Grobbee [Pays-Bas] ; Pavel Hamet [Canada] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Australie] ; Michel Marre [France] ; Bruce Neal [Australie] ; Anushka Patel [Australie] ; Mark Woodward [Australie, États-Unis] ; John Chalmers [Australie] | Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial |
| 008447 |
Andre-Pascal Kengne [Australie] ; Sébastien Czernichow [France] ; Rachel Huxley [Australie] ; Diederick Grobbee [Pays-Bas] ; Mark Woodward [États-Unis] ; Bruce Neal [Australie] ; Sophia Zoungas [Australie] ; Mark Cooper [Australie] ; Paul Glasziou [Royaume-Uni] ; Pavel Hamet [Canada] ; Stephen B. Harrap [Australie] ; Giuseppe Mancia [Italie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; John Chalmers [Australie] | Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE |
| 008475 |
Toshiharu Ninomiya [Australie] ; Vlado Perkovic [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Sophia Zoungas [Australie] ; Avinesh Pillai [Australie] ; Meg Jardine [Australie] ; Anushka Patel [Australie] ; Alan Cass [Australie] ; Bruce Neal [Australie] ; Neil Poulter [Royaume-Uni] ; Carl-Erik Mogensen [Danemark] ; Mark Cooper [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Pavel Hamet [Canada] ; Giuseppe Mancia [Italie] ; Mark Woodward [Australie, États-Unis] ; Stephen Macmahon [Australie] ; John Chalmers [Australie] | Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes |
| 009E18 |
Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Craig Anderson [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Stephen Davis [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] | Lower target blood pressures are safe and effective for the prevention of recurrent stroke : the PROGRESS trial |
| 00A462 |
Bruce Neal [Australie] ; Athanase Benetos [France] ; Frédérique Thomas [France] ; Kathryn E. Bean [France] ; Bruno Pannier [France] ; Louis Guize [France] | Role of modifiable risk factors in life expectancy in the elderly. Commentary |
| 00A499 |
Pierre Amarenco [France] ; Anushka Patel [France] ; Mark Woodward [France] ; Duncan J. Campbell [Australie] ; David R. Sullivan [Australie] ; Samuel Colman [France] ; John Chalmers [France] ; Bruce Neal [France] ; Stephen Macmahon [France] | Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease |
| 00A663 |
Carole Dufouil [France] ; John Chalmers [Australie] ; Oguzhan Coskun [France] ; Véronique Besancon [France] ; Marie-Germaine Bousser [France] ; Pierre Guillon [France] ; Stephen Macmahon [Australie] ; Bernard Mazoyer [France] ; Bruce Neal [Australie] ; Mark Woodward [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Christophe Tzourio [France, Australie] | Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy |
| 00B023 |
Stephen B. Harrap [Australie] ; Christophe Tzourio [France] ; Francois Cambien [France] ; Odette Poirier [France] ; Segolene Raoux [France] ; John Chalmers [Australie] ; Neil Chapman [Australie] ; Samuel Colman [Australie] ; Solenn Leguennec [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Takayoshi Ohkubo [Australie] ; Mark Woodward [Australie] | The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition |
